Current Standards of Treatment in MS and the Role of Oral Agents
J Clin Psychiatry 2014;75(7):e19
© Copyright 2016 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Multiple sclerosis (MS) is a devastating disease causing weakness, fatigue, cognitive problems, and other disabilities. Relapses cause significant functional impairment and decreased quality of life for patients with MS, and relapses are typically treated with short-term corticosteroids. Long-term treatment for relapsing MS consists of several types of disease-modifying therapies, most of which are administered by either IV or injection. While these therapies are effective, newer oral agents are now available. Although more long-term data are needed, oral agents may be more convenient and tolerable than injections or IVs and should be presented to patients as a potential therapy option.
See the entire activity.